Atomo Secures $410,000 Order From Lumos to Support FebriDx Rollout in US; Shares Down 5%

MT Newswires Live

Aug 07, 2025

Atomo Diagnostics (ASX:AT1) said its strategic partner Lumos Diagnostics (ASX:LDX) placed an order with the company for the supply of $410,000 worth of Pascal cassettes to support scaling up the demand for the company's diagnostic product, FebriDx, in the US market, according to a Thursday Australian bourse filing.

The company said that Lumos indicated that it expects the agreement with Phase to generate FebriDx product sales of up to $316 million over six years, assuming that the clinical laboratory improvement amendments (CLIA) waiver is granted and contracted minimum order quantities are achieved.

The FebriDx test secured a 510k clearance from the US Food and Drug Administration and is currently well progressed through a CLIA waiver study that is expected to be completed this month.

Atomo Diagnostics' shares fell 5% in recent Thursday trade. Lumos Diagnostics' shares jumped almost 6%, earlier hitting their highest since September 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2557538323"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557538323\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557538323?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-07 12:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557538323","market":"sh","top_or_hot":-1,"title":"Atomo Secures $410,000 Order From Lumos to Support FebriDx Rollout in US; Shares Down 5%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/AT1.AU\">Atomo Diagnostics</a> (ASX:AT1) said its strategic partner <a href=\"https://laohu8.com/S/LDXHF\">Lumos Diagnostics</a> (ASX:LDX)  placed an order with the company for the supply of $410,000 worth of Pascal cassettes to support scaling up the demand for the company's diagnostic product, FebriDx, in the US market, according to a Thursday Australian bourse filing.</p><p>The company said that Lumos indicated that it expects the agreement with Phase to generate FebriDx product sales of up to $316 million over six years, assuming that the clinical laboratory improvement amendments (CLIA) waiver is granted and contracted minimum order quantities are achieved.</p><p>The FebriDx test secured a 510k clearance from the US Food and Drug Administration and is currently well progressed through a CLIA waiver study that is expected to be completed this month.</p><p>Atomo Diagnostics' shares fell 5% in recent Thursday trade. <a href=\"https://laohu8.com/S/LDX.AU\">Lumos Diagnostics</a>' shares jumped almost 6%, earlier hitting their highest since September 2023.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Atomo Secures $410,000 Order From Lumos to Support FebriDx Rollout in US; Shares Down 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAtomo Secures $410,000 Order From Lumos to Support FebriDx Rollout in US; Shares Down 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-07 12:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/AT1.AU\">Atomo Diagnostics</a> (ASX:AT1) said its strategic partner <a href=\"https://laohu8.com/S/LDXHF\">Lumos Diagnostics</a> (ASX:LDX)  placed an order with the company for the supply of $410,000 worth of Pascal cassettes to support scaling up the demand for the company's diagnostic product, FebriDx, in the US market, according to a Thursday Australian bourse filing.</p><p>The company said that Lumos indicated that it expects the agreement with Phase to generate FebriDx product sales of up to $316 million over six years, assuming that the clinical laboratory improvement amendments (CLIA) waiver is granted and contracted minimum order quantities are achieved.</p><p>The FebriDx test secured a 510k clearance from the US Food and Drug Administration and is currently well progressed through a CLIA waiver study that is expected to be completed this month.</p><p>Atomo Diagnostics' shares fell 5% in recent Thursday trade. <a href=\"https://laohu8.com/S/LDX.AU\">Lumos Diagnostics</a>' shares jumped almost 6%, earlier hitting their highest since September 2023.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LDX.AU","symbol_name":"LUMOS DIAGNOSTICS HOLDINGS L","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2557538323","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557538323","pubTimestamp":1754539860,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Atomo Diagnostics  said its strategic partner Lumos Diagnostics   placed an order with the company for the supply of $410,000 worth of Pascal cassettes to support scaling up the demand for the company's diagnostic product, FebriDx, in the US market, according to a Thursday Australian bourse filing.The company said that Lumos indicated that it expects the agreement with Phase to generate FebriDx product sales of up to $316 million over six years, assuming that the clinical laboratory improvement amendments  waiver is granted and contracted minimum order quantities are achieved.The FebriDx test secured a 510k clearance from the US Food and Drug Administration and is currently well progressed through a CLIA waiver study that is expected to be completed this month.Atomo Diagnostics' shares fell 5% in recent Thursday trade. Lumos Diagnostics' shares jumped almost 6%, earlier hitting their highest since September 2023.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LDX.AU":"LUMOS DIAGNOSTICS HOLDINGS L","AT1.AU":"ATOMO DIAGNOSTICS LTD","BK7501":"新冠治疗股","BK7126":"医疗保健用品","BK7007":"医疗保健设备","CLIA":"VERIDIEN CLIMATE ACTION ETF"},"translate_title":"Atomo从Lumos获得410,000美元的订单，以支持FebriDx在美国的推出；股价下跌5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LDX.AU":0.9,"AT1.AU":0.9,"CLIA":1},"content_text":"Atomo Diagnostics (ASX:AT1) said its strategic partner Lumos Diagnostics (ASX:LDX)  placed an order with the company for the supply of $410,000 worth of Pascal cassettes to support scaling up the demand for the company's diagnostic product, FebriDx, in the US market, according to a Thursday Australian bourse filing.The company said that Lumos indicated that it expects the agreement with Phase to generate FebriDx product sales of up to $316 million over six years, assuming that the clinical laboratory improvement amendments (CLIA) waiver is granted and contracted minimum order quantities are achieved.The FebriDx test secured a 510k clearance from the US Food and Drug Administration and is currently well progressed through a CLIA waiver study that is expected to be completed this month.Atomo Diagnostics' shares fell 5% in recent Thursday trade. Lumos Diagnostics' shares jumped almost 6%, earlier hitting their highest since September 2023.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}